Anthropic gave AI a dose of "evil" during training to help it resist bad behavior later on. The company said the method works like a vaccine to build resilience. Anthropic's research comes as AI ...

Explore France's groundbreaking HPAI vaccination strategy, cutting outbreak risks and transforming poultry sector resilience.

COPENHAGEN, Denmark, October 8, 2025 - Evaxion A/S (EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, is launching a significant ...

A research group funded by tech billionaire Larry Ellison is set to invest £118 million ($169.6 million) in applying AI to vaccine research with the UK's Oxford University.… Oxford Vaccine Group is ...

A child receives a dose of polio vaccine during a door-to-door vaccination campaign in Karachi on September 9 - Copyright AFP Rizwan TABASSUM A child receives a dose ...

The FDA has cleared Everest Medicine's EVM14 cancer vaccine application, and its EVM16 vaccine has been administered on the first patient under an investigator-initiated trial Everest Medicines has ...

Researchers used AI to identify an mpox protein that triggers a strong immune response in mouse models. The discovery could pave the way to more effective vaccines and therapies for mpox. The ...

The I-29 Moo University dairy webinar series continues from noon to 1 p.m. May 8 focusing on an avian influenza vaccine development with Dr. Alan Young. Dr. Young founded VST/Medgene Labs to assist in ...

When news of the efficacy of the Covid-19 vaccine was first shared, the medical community was astounded not only by the vaccine’s ability to protect people from infection but also by the speed at ...

Researchers at WashU Medicine have developed a nasal vaccine against the highly pathogenic H5N1 avian influenza virus which ...

Viral vectors and vaccines navigate public distrust while advancing through AI design, COVID response lessons, and promising ...

Artificial intelligence’s (AI) predictive capabilities will help the vaccine industry optimize manufacturing, reduce production costs, and increase patient access to lifesaving jabs. That, at least, ...